PWP Deal flow 2025?
Curious how PWP has been doing in 2025? Seems like they haven’t really been on much this year compared to last but curious if anyone has insights
Curious how PWP has been doing in 2025? Seems like they haven’t really been on much this year compared to last but curious if anyone has insights
| +125 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 22 | 15m |
| +85 | Incompetent and annoying co-intern | 23 | 1d |
| +70 | Getting Laid in IB? | 28 | 3d |
| +67 | Intern keeps sleeping at work - what to tell them | 28 | 1d |
| +55 | Living in greenwich as an analyst? | 12 | 23h |
| +42 | NYC Associate Budget | 14 | 1d |
| +40 | UBS Promotion or Lateral to Boutique? | 9 | 45m |
| +36 | Nauseous every morning for past 3 years in IB, anyone else? | 21 | 2d |
| +36 | Quick Thoughts on CVC AI Sale Process | 7 | 1d |
| +35 | PJT M&A Group Selection 2026 | 5 | 1h |
Career Resources
Things are shitty, healthcare team lost a senior MD. Other groups (excl. RX maybe) are struggling too. Fintech team is a joke, FIG team has only done 2 Blackrock deals last year (which is great and all but it's a one trick pony group), and C&R is an internal joke as they only pitch with 0% chance of winning any mandate.
Damn fr? Saw good q1 results but didnt realize the situation was so bad
I thought C&R was one of the better teams on the street???
Lmao, just look at their deal flow (or lack of)
I am at another EB but my friend works there. Overall the bank is doing quite well and are on track for another great year (great Q1 results, consistent growth QoQ and YoY), but it is driven by a few very strong groups.
Healthcare is a powerhouse, albeit slightly slower deal flow than last year as of now. No one was surprised when the partner who moved to Citi left – he hadn’t been productive/good fit. RX team are monsters, super lean and one of the top shops on the street now despite only having 6 partners. Industrials had some difficulties in the past but have had some great mandates lately. FIG runs lean also so great deal exposure if you can swing the asset management side. Fintech is small so even if they don't close a lot of deals they pay for themselves off of a few deals and coast the rest of the year – great lifestyle (no clue on the specific policy but out of office at like 5, limited friday/weekend work, etc and still get top of street pay). C&R isn't great, and can't say much about tech.
Also they get paid near top of street, 190-200k A1, 400k ASO1, 490k as ASO2, etc.
Bump
Pretty bad
bump
Consumer is dead. Brought some people from HL to try and fix it.
No deal flow so won't be surprised if they cut some seniors
Any chance analysts will be affected?
So much for the "next CVP/PJT" narrative some PWP shills tried to lead here lmao
PJT M&A shill is for real.
Et sint aut exercitationem. Voluptatem qui quas aliquid. Commodi occaecati consequuntur maiores vel nobis sit praesentium.
Atque voluptatem odio enim ut nobis minima. Et nihil tempora qui aut aperiam velit. Autem veritatis esse voluptas labore id.
Accusamus labore tempore et dignissimos est rem qui. Adipisci dolorem voluptatem odit consequatur animi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...